jump to the main content
jump to the bottom of the page

Contenido en español
Contingut en català
Current language Spanish

COLLABORATE El Meu Clínic

Contenido en español
Contingut en català
Current language Spanish

José Alcamí

Research group

AIDS and HIV infection Accredited researcher (R3A)

alcami@clinic.cat 0000-0003-0023-7377

Follow it on:

The twitter of José . This link opens in a new tab.

Featured publications

Association of a single nucleotide polymorphism in the ubxn6 gene with long-term non-progression phenotype in HIV-positive individuals

Authors:
Díez-Fuertes F; De La Torre-Tarazona H; Calonge E; Pernas M; Bermejo M;

(...)

López-Galíndez C; Lathrop M; Dopazo J; Sakuntabhai A; Alcamí J.

Reference: Clinical Microbiology And Infection 2020.
Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors.

Authors:
Bermejo M; Ambrosioni J; Bautista G; Climent N; Mateos E;

(...)

Cervantes F; Plana M; Miró JM; Alcamí J; Coiras M .

Reference: Biochemical Pharmacology 2018.
Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection

Authors:
Garcia, Felipe; Lejeune, Merylene; LEJEUNE, MARYLÈNE MARIE; Climent, Nuria; Gil, Cristina;

(...)

Joseph, Joan; Miro, Jose M; Pumarola, Tomas; Gatell, Jose M; Gallart, Teresa.

Reference: Journal Of Infectious Diseases 2005.
Absolute dependence on κB responsive elements for initiation and tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes

Authors:
Alcami J; Lain de Lera T; Folgueira L; Pedraza M; Jacque J;

(...)

Hay R; Harrich D; Gaynor R; Virelizier J; Arenzana-Seisdedos F.

Reference: Embo Journal 1995.

Featured Projects

TYROSINE KINASE INHIBITION: THE NEW FRONT IN HIV CURE EFFORTS.

Principal investigator: JOSÉ ALCAMI PERTEJO

Funder: Instituto de Salud Carlos III (Sede o evento)

Code: GRANT NUMBER: 1R01AI143567-01 / FAIN: R01AI143567

Duration: 07/11/2018 - 31/10/2023
MECANISMOS DE RESTRICCIÓN A LA INFECCIÓN Y PROGRESIÓN DE LA INFECCIÓN POR EL VIH.

Funder: Instituto de Salud Carlos III (Sede o evento)

Duration: 01/01/2017 - 31/12/2019
RED ESPAÑOLA DE INVESTIGACIÓN EN SIDA (RIS)

Principal investigator: José Alcami Pertejo

Funder: Instituto de Salud Carlos III (Sede o evento)

Code: RD16/0025/0012

Duration: 01/01/2017 - 31/12/2021
EAVI 2020: EUROPEAN AIDS VACCINE INITIATIVE 2020

Principal investigator: José Alcami Pertejo

Funder: Instituto de Salud Carlos III (Sede o evento); Unión Europea

Duration: 01/11/2015 - 01/11/2020
AIM-AIV: HYDROXITIROSOL, A NEW GENERATION OF MICROBICIDES TARGETIN HIV THROUGH ANTIVIRAL AND ANTI-INFAMMATORY PATHWAYS

Principal investigator: José Alcami Pertejo, José Alcamí Pertejo

Funder: Instituto de Salud Carlos III (Sede o evento); UE

Code: U.E. 305938

Duration: 01/12/2012 - 01/12/2014